Select Medical Holdings Toekomstige groei
Future criteriumcontroles 1/6
Select Medical Holdings is forecast to grow earnings and revenue by 5.7% and 4.7% per annum respectively. EPS is expected to grow by 3.1% per annum. Return on equity is forecast to be 11.9% in 3 years.
Belangrijke informatie
5.7%
Groei van de winst
3.1%
Groei van de winst per aandeel
Healthcare winstgroei | 20.1% |
Inkomstengroei | 4.7% |
Toekomstig rendement op eigen vermogen | 11.9% |
Dekking van analisten | Low |
Laatst bijgewerkt | 02 Nov 2024 |
Recente toekomstige groei-updates
Recent updates
Select Medical Holdings' (NYSE:SEM) Dividend Will Be $0.125
Nov 04Returns Are Gaining Momentum At Select Medical Holdings (NYSE:SEM)
Oct 21Select Medical Holdings: No Reason To Downgrade This One Just Yet
Oct 07Does Select Medical Holdings (NYSE:SEM) Have A Healthy Balance Sheet?
Oct 03Select Medical Holdings' (NYSE:SEM) Dividend Will Be $0.125
Aug 05Select Medical Holdings' (NYSE:SEM) Returns On Capital Are Heading Higher
Jul 19What Does Select Medical Holdings Corporation's (NYSE:SEM) Share Price Indicate?
Jul 01Does Select Medical Holdings (NYSE:SEM) Have A Healthy Balance Sheet?
Jun 13There's Reason For Concern Over Select Medical Holdings Corporation's (NYSE:SEM) Price
May 26Results: Select Medical Holdings Corporation Exceeded Expectations And The Consensus Has Updated Its Estimates
May 05Here's Why Shareholders Should Examine Select Medical Holdings Corporation's (NYSE:SEM) CEO Compensation Package More Closely
Apr 19Returns At Select Medical Holdings (NYSE:SEM) Appear To Be Weighed Down
Apr 11Select Medical: Solid Growth Prospects And A Compelling Valuation
Mar 05Cautious Investors Not Rewarding Select Medical Holdings Corporation's (NYSE:SEM) Performance Completely
Feb 18We Think Select Medical Holdings (NYSE:SEM) Is Taking Some Risk With Its Debt
Jan 15Returns On Capital At Select Medical Holdings (NYSE:SEM) Have Hit The Brakes
Dec 31Select Medical Holdings (NYSE:SEM) Is Due To Pay A Dividend Of $0.125
Nov 06Select Medical: Market Expectations Appear Well Justified With Technical And Economic Factors
Oct 25What Does Select Medical Holdings Corporation's (NYSE:SEM) Share Price Indicate?
Oct 04Is Select Medical Holdings (NYSE:SEM) Using Too Much Debt?
Sep 16Select Medical: Capital Charge Now $6.1Bn At C.6% Trailing Returns, Reiterate Hold
Aug 11Select Medical Holdings (NYSE:SEM) Will Pay A Dividend Of $0.125
Aug 07Select Medical Holdings (NYSE:SEM) Has More To Do To Multiply In Value Going Forward
Jul 14At US$31.69, Is Select Medical Holdings Corporation (NYSE:SEM) Worth Looking At Closely?
Jun 29Here's Why Select Medical Holdings (NYSE:SEM) Has A Meaningful Debt Burden
May 27Select Medical: Revising To Hold As Business Economics Roll Lower
May 26Select Medical Holdings (NYSE:SEM) May Have Issues Allocating Its Capital
Apr 05Should You Investigate Select Medical Holdings Corporation (NYSE:SEM) At US$25.73?
Mar 17Select Medical GAAP EPS of $0.22 misses by $0.11, revenue of $1.58B in-line
Feb 23Here's Why Select Medical Holdings (NYSE:SEM) Has A Meaningful Debt Burden
Jan 31The Returns On Capital At Select Medical Holdings (NYSE:SEM) Don't Inspire Confidence
Dec 20Is Now An Opportune Moment To Examine Select Medical Holdings Corporation (NYSE:SEM)?
Dec 01Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
12/31/2026 | 7,782 | 306 | N/A | N/A | 2 |
12/31/2025 | 7,357 | 462 | N/A | N/A | 5 |
12/31/2024 | 7,050 | 432 | N/A | N/A | 5 |
9/30/2024 | 6,969 | 266 | 353 | 572 | N/A |
6/30/2024 | 6,873 | 259 | 288 | 507 | N/A |
3/31/2024 | 6,788 | 260 | 241 | 464 | N/A |
12/31/2023 | 6,664 | 235 | 353 | 582 | N/A |
9/30/2023 | 6,587 | 217 | 191 | 415 | N/A |
6/30/2023 | 6,489 | 196 | 177 | 393 | N/A |
3/31/2023 | 6,399 | 174 | 128 | 330 | N/A |
12/31/2022 | 6,334 | 153 | 94 | 285 | N/A |
9/30/2022 | 6,312 | 175 | 21 | 212 | N/A |
6/30/2022 | 6,278 | 223 | 19 | 216 | N/A |
3/31/2022 | 6,258 | 329 | -20 | 168 | N/A |
12/31/2021 | 6,205 | 389 | 221 | 401 | N/A |
9/30/2021 | 6,105 | 415 | 503 | 669 | N/A |
6/30/2021 | 5,995 | 415 | 553 | 705 | N/A |
3/31/2021 | 5,664 | 306 | 1,077 | 1,224 | N/A |
12/31/2020 | 5,532 | 250 | 882 | 1,028 | N/A |
9/30/2020 | 5,446 | 206 | 860 | 999 | N/A |
6/30/2020 | 5,415 | 162 | 859 | 998 | N/A |
3/31/2020 | 5,544 | 155 | 300 | 448 | N/A |
12/31/2019 | 5,454 | 143 | 288 | 445 | N/A |
9/30/2019 | 5,344 | 136 | 210 | 380 | N/A |
6/30/2019 | 5,218 | 138 | 235 | 410 | N/A |
3/31/2019 | 5,153 | 140 | 308 | 485 | N/A |
12/31/2018 | 5,081 | 133 | 327 | 494 | N/A |
9/30/2018 | 4,911 | 207 | 309 | 489 | N/A |
6/30/2018 | 4,720 | 193 | N/A | 415 | N/A |
3/31/2018 | 4,527 | 189 | N/A | 345 | N/A |
12/31/2017 | 4,365 | 171 | N/A | 238 | N/A |
9/30/2017 | 4,300 | 93 | N/A | 196 | N/A |
6/30/2017 | 4,259 | 82 | N/A | 209 | N/A |
3/31/2017 | 4,237 | 74 | N/A | 180 | N/A |
12/31/2016 | 4,217 | 112 | N/A | 347 | N/A |
9/30/2016 | 4,211 | 121 | N/A | 286 | N/A |
6/30/2016 | 4,178 | 143 | N/A | 312 | N/A |
3/31/2016 | 3,973 | 146 | N/A | 282 | N/A |
12/31/2015 | 3,683 | 127 | N/A | 208 | N/A |
9/30/2015 | 3,420 | 123 | N/A | 222 | N/A |
6/30/2015 | 3,165 | 121 | N/A | 204 | N/A |
3/31/2015 | 3,052 | 119 | N/A | 224 | N/A |
12/31/2014 | 3,020 | 117 | N/A | 171 | N/A |
9/30/2014 | 2,997 | 121 | N/A | 230 | N/A |
6/30/2014 | 2,963 | 118 | N/A | 213 | N/A |
3/31/2014 | 2,949 | 111 | N/A | 188 | N/A |
12/31/2013 | 2,938 | 112 | N/A | 193 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: SEM's forecast earnings growth (5.7% per year) is above the savings rate (2.5%).
Winst versus markt: SEM's earnings (5.7% per year) are forecast to grow slower than the US market (15.4% per year).
Hoge groeiwinsten: SEM's earnings are forecast to grow, but not significantly.
Omzet versus markt: SEM's revenue (4.7% per year) is forecast to grow slower than the US market (8.9% per year).
Hoge groei-inkomsten: SEM's revenue (4.7% per year) is forecast to grow slower than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: SEM's Return on Equity is forecast to be low in 3 years time (11.9%).